SOD1 and pulmonary fibrosis: Down-regulates MDA, TNF-α and IL-6 expression; increases SOD activity; inhibits epithelial–mesenchymal transition; and slows the development of pulmonary fibrosis by inhibiting oxidative stress and inflammation in the lung tissues of mice with pulmonary fibrosis.